Contraceptive prevalence, any modern method in Cameroon
Cameroon: Contraceptive prevalence, any modern method was 15.4% in 2018. ▲ Rising
Contraceptive prevalence, any modern method in Cameroon, 1991–2018
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
Cameroon recorded 15.4% for contraceptive prevalence, any modern method in 2018.
Compared with earlier readings it is up 10.1% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Cameroon peaked at 19.9% in 2014 and was at its lowest, 4.3%, in 1991.
Cameroon ranks 105th of 113 countries on this measure, in the bottom quarter.
Contraceptive prevalence, any modern method in Cameroon, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1991 | 4.3% | — |
| 1998 | 7.1% | +65.1% |
| 2004 | 12.5% | +76.1% |
| 2006 | 14.0% | +11.9% |
| 2011 | 14.4% | +2.9% |
| 2014 | 19.9% | +38.4% |
| 2018 | 15.4% | -22.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 5.7% | 4.3% | 7.1% | 2 |
| 2000s | 13.2% | 12.5% | 14.0% | 2 |
| 2010s | 16.6% | 14.4% | 19.9% | 3 |
Countries ranked near Cameroon
More health data for Cameroon
- Un projection of annual infant deaths, annual growth rate -1.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7821 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 786.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12,841 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 17 (2025)
- Population ages 00-04, female, annual growth rate 1.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0746 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.21 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Cameroon?
- Contraceptive prevalence, any modern method in Cameroon was 15.4% in 2018, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Cameroon?
- The highest recorded value was 19.9% in 2014.
- What is the lowest contraceptive prevalence, any modern method recorded in Cameroon?
- The lowest recorded value was 4.3% in 1991.
- How does Cameroon rank for contraceptive prevalence, any modern method?
- Cameroon ranks 105th out of 113 countries with data for 2018.
- Is contraceptive prevalence, any modern method rising or falling in Cameroon?
- Over the last ten years it is up 10.1%. The long-run trend across the full record is rising.
- Where does this Cameroon data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.